JPRN-jRCT2090220288
Completed
Phase 2
Clinical trials for the verification of safety and efficiency of tamibarotene for the treatment of Alzheimer's disease - Clinical trials of tamibarotene for Alzheimer's disease
Fumihiko Yasuno0 sites50 target enrollmentApril 13, 2017
ConditionsAlzheimer's disease
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Alzheimer's disease
- Sponsor
- Fumihiko Yasuno
- Enrollment
- 50
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •The patients of Alzheimer's disease with mild and moderate cognitive disfunction(15\<MMSE score\<27\)
Exclusion Criteria
- •The use of other drugs of clinical trials
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A clinical trial for the validation of safety and efficacy of the implant-type tissue-engineered cartilage using autologous cells.Severe nasal deformity in orofacial cleft, that needs nasal augmentation and nasal tip correctionJPRN-UMIN000017734The University of Tokyo Hospital2
Recruiting
Not Applicable
Clinical trial to verify the efficacy and safety of improvement of lower extremity muscle function and balance therapy using Electric Orthopedic Exercise Device(WALK WELL™) in hemiplegic stroke patientsKCT0004558Chonbuk National University Hospital30
Active, not recruiting
Phase 3
Clinical trial for evaluation of efficacy and safety of the therapeutic device(RP-14) based on disinfection technique utilizing photolysis of hydrogen peroxide for moderate-severe chronic periodontitisJPRN-UMIN000016791Tohoku University Graduate School of Dentistry55
Active, not recruiting
Phase 2
Clinical trials to evaluate the efficacy and safety of Scleral contact lens,OPS01Corneal astigmatism that cannot use existing RGP contact lenses and soft contact lenses.JPRN-jRCT2032230323Tasaka Tetsuya25
Recruiting
Phase 1
SHED for cerebral palsyJPRN-jRCTb040230042Sato Yoshiaki3